Tetrabenazine
Other Nervous System Drugs
Sold as NITOMAN · XENAZINE 25
- Drug class
- Other Nervous System Drugs
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 12
Overview
Tetrabenazine is an active pharmaceutical ingredient in the Other Nervous System Drugs group (N07XX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 9 | May 22, 2026 |
| CA Canada | Health Canada | 3 | March 18, 2026 |
GBUnited Kingdom· MHRA
9 products
Uses
Tetrabenazine is indicated for hyperkinetic motor disorders with Huntington’s chorea.
How to take
CACanada· Health Canada
3 products
Uses
AND CLINICAL USE pms-TETRABENAZINE (tetrabenazine) has been found useful in the treatment of hyperkinetic movement disorders such as Huntington’s chorea, hemiballismus, senile chorea, tic and Gille’s de la Tourette’s syndrome and tardive dyskinesia.
Tetrabenazine is not indicated for the treatment of levodopa-induced dyskinetic/choreiform movements (See WARNINGS). Tetrabenazine should only be used by (or in consultation with) physicians who are experienced in the treatment of hyperkinetic movement disorders.
CONTRAINDICATIONS pms-TETRABENAZINE (tetrabenazine) is contraindicated: in patients with a known hypersensitivity to the drug or to any of the components of the formulation. in patients with currently untreated or inadequately treated episodes of clinical depression (See WARNINGS).
in patients with a history of depression, including those with a current episode of depression being satisfactorily treated, pms-TETRABENAZINE should not be used unless the patient is under the care of a supervising psychiatrist experienced with the patient’s disorder and tetrabenazine’s pharmacology in patients taking a monoamine oxidase inhibitor (MAOI).
Drug interactions
Known interactions involving Tetrabenazine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 479. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL403110005 · revised May 22, 2026
- [2]Health Canada (DPD) · 02402424 · revised March 18, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.